To try to
block elastase, biochemist Drew Smith of NeXstar Pharmaceuticals in Boulder, Colorado, earlier this year synthesized a nucleic acid sequence called an aptamer, which is designed for its shape.
It also
blocks the action of enzymes which degrade tissue such as collagenase,
elastase, and hyaluronidase (Chainani, 2003).